10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
| Status: | Recruiting |
|---|---|
| Conditions: | Psoriasis, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 2 - 17 |
| Updated: | 12/14/2017 |
| Start Date: | June 27, 2005 |
| End Date: | December 2026 |
| Contact: | Valeant Pharmaceuticals |
| Phone: | 908-927-1400 |
A Prospective 10 Year Observational Registry of Pediatric Subjects (Age Greater Than or Equal to Two Years to Age Less Than or Equal to 17 Years) With Atopic Dermatitis Who Have Used Elidel Cream 1% (Pimecrolimus)
This study will examine the risk of systemic malignancies in pediatric patients with atopic
dermatitis exposed to Elidel 1% cream.
dermatitis exposed to Elidel 1% cream.
Registry study to examine the risk of systemic malignancies in pediatric patients with atopic
dermatitis exposed to Elidel 1% cream.
dermatitis exposed to Elidel 1% cream.
Inclusion Criteria:
- males and females
- greater than or equal to 2 years and less than or equal to 17 years at enrollment
- diagnosis of atopic dermatitis (confirmed by treating physician)
- applied pimecrolimus cream 1 % 6 weeks out of past 24 weeks
Exclusion Criteria:
- past or present history of systemic malignancy, skin malignancy, or
lymphoproliferative disease
- past or present use of oral immunosuppressive therapy
We found this trial at
1
site
Click here to add this to my saved trials
